All Stories

  1. Three-Dimensional Echocardiography and Global Longitudinal Strain in Follow-up after MIS-C
  2. The Influence of SARS-CoV-2 Variants B.1.1.7 and B.1.617.2 on a Different Clinical Course and Severity of COVID-19 in Children Hospitalized in 2021 Compared With 2020
  3. Clinical Course and Severity of COVID-19 in 940 Infants with and without Comorbidities Hospitalized in 2020 and 2021: The Results of the National Multicenter Database SARSTer-PED
  4. In vitro dissolution test of ketoprofene: development and evaluation of release from soft and hard gelatine capsules
  5. Response to the letter to the Editor regarding the article “Vaccine versus infection - COVID-19-related loss of training time in elite athletes”
  6. Adult pneumococcal vaccination – new opportunities
  7. Vaccine or Garlic–Is It a Choice? Awareness of Medical Personnel on Prevention of Influenza Infections
  8. Upper respiratory tract infections and influenza-like illnesses among healthcare workers: are serological tests useful in monitoring influenza and influenza-like illness?
  9. Vaccine versus infection – COVID-19-related loss of training time in elite athletes
  10. Coalition Shaping the Vaccination Landscape
  11. Newborn screening and gene therapy in SMA: Challenges related to vaccinations
  12. Exposure to non-opioid analgesics during pregnancy and the risk of adverse drug reactions
  13. Analysis of 21 appendices from children with multisystem inflammatory syndrome compared to specimens of acute appendicitis – a new insight into MIS-C pathology
  14. Sports Elite Means Vaccine Elite? Concerns and Beliefs Related to COVID-19 Vaccines among Olympians and Elite Athletes
  15. A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related study
  16. Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome
  17. Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study
  18. Effects of Non-Opioid Analgesics on the Cell Membrane of Skin and Gastrointestinal Cancers
  19. Streptococcus intermedius Acute Meningitis in an Immunocompetent Child
  20. COVID-19 infections in infants
  21. Authors’ response to Dr Finsterer's comment “Exclude differentials before diagnosing SARS-CoV-2-associated acute hemorrhagic necrotizing encephalitis” (THEIJID-D-22-00008)
  22. Post-exposure prophylaxis in cases of injury – rules of conduction
  23. The case of fatal acute hemorrhagic necrotizing encephalitis in a two-month-old boy with Covid-19.
  24. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
  25. Treatment of Autoinflammatory Diseases
  26. Anti-Inflammatory Therapy of Infections
  27. Non-Cardiac Sequelae of Kawasaki Disease in 3 Months Follow Up Period
  28. Elite athletes with COVID-19 — Predictors of the course of disease
  29. Guidelines for immunization of children following multisystem inflammatory syndrome in children
  30. Pneumococcal vaccination among adults – updated Polish recommendations
  31. Recommendations of the Polish Paediatric Society, the Polish Society of Vaccinology, and the Polish Society of Family Medicine on meningococcal vaccinations in children and adults in Poland
  32. Updated principles of prevention, diagnosis and treatment of COVID-19 in children in Poland – recommendations for paediatricians and family medicine doctors
  33. Orchiepididymitis in a 14-year-old boy with concurrent SARS-CoV-2 infection
  34. COVID-19 immunizations in occupational medicine
  35. Distinct characteristics of multisystem inflammatory syndrome in children in Poland
  36. Clinical and Epidemiological Characteristics of 1283 Pediatric Patients with Coronavirus Disease 2019 during the First and Second Waves of the Pandemic—Results of the Pediatric Part of a Multicenter Polish Register SARSTer
  37. Pneumonia, gastrointestinal symptoms, comorbidities, and coinfections as factors related to a lengthier hospital stay in children with COVID-19—analysis of a paediatric part of Polish register SARSTer
  38. Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS‐C)
  39. An Infant With Seborrhoeic Dermatitis and Eczema Herpeticum Complicated by a Generalized Infection
  40. A 10-Year-old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir
  41. The Impact of a Single Educational Lecture on the Vaccine Confidence among Pregnant Women and Young Mothers
  42. Protocol of the study: the effectiveness of pleuran in the treatment of acute gastroenteritis in children—a randomised, placebo-controlled, double-blind trial (EPTAGE)
  43. Epidemiology, diagnosis, and prevention of tick-borne encephalitis in Poland and selected european countries – a position statement of the polish group of experts
  44. Fever and Diarrhea as the Only Symptoms of Multisystem Inflammatory Syndrome in Children
  45. ASSESSMENT OF SAFETY OF PAIN CONTROL BY NON-OPIOID OVER-THE COUNTER MEDICATIONS
  46. Cutaneous larva migrans in a beach volleyball player
  47. SARS-CoV-2 Cluster in Nursery, Poland
  48. Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update – February 2021
  49. Recommendations for primary healthcare doctors for the management of acute respiratory infections in children during the SARS-CoV-2 pandemic – COVID COMPASS
  50. Pediatric Inflammatory Multisystem Syndrome (PIMS) Did Occur in Poland during Months with Low COVID-19 Prevalence, Preliminary Results of a Nationwide Register
  51. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland
  52. Development of child immunity in the context of COVID-19 pandemic
  53. Kleszczowe zapalenie mózgu u 9-letniego chłopca – choroba, której można było uniknąć
  54. Vaccinations in rheumatic diseases
  55. A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention
  56. Safety and Impact on Training of the Influenza Vaccines in Elite Athletes Participating in the Rio 2016 Olympics
  57. Recommendations for the prevention, diagnosis and treatment of inFLUenza in adults for Primary care physiciAnS: FLU COMPAS PCP – ADULTS
  58. The clinical course of gastroenteritis due to nosocomial and community acquired norovirus infections in immunocompromised and immunocompetent children – single center experience
  59. Acute renal failure due to leptospirosis. Diagnostic challenges – a case report
  60. Antibiotic usage at a clinical paediatric hospital before and after the implementation of actions related to the hospital antibiotic policy
  61. Spleen: Consequences of Lack of Function
  62. THE USE OF OTC HERBAL SEDATIVES BY PHARMACY PATIENTS – A QUESTIONNAIRES-BASED SURVEY STUDY
  63. Atypical course of varicella-zoster infection in a child with acute lymphoblastic leukaemia
  64. Severe Hyponatremia in a 6-month-old Infant
  65. Przeczucie matki czy ocena lekarzy? Przypadek siedmiomiesięcznego niemowlęcia z gorączką
  66. Zapalenie opon mózgowo-rdzeniowych wywołane przez meningokoki serogrupy B – opis przypadku oraz analiza medycznego zdarzenia niepożądanego
  67. Decreasing Vaccination Coverage Against Hepatitis B and Tuberculosis in Newborns
  68. Autologous Platelet-Rich Plasma Reduces Healing Time of Chronic Venous Leg Ulcers: A Prospective Observational Study
  69. Genetic Predisposition for Osteoporosis and Fractures in Postmenopausal Women
  70. ReCOMmendations for the treatment of INFLUENZA in children for Primary care physiciAnS – COMPAS INFLUENZA
  71. Vaccination Against Measles, Mumps, and Rubella in the Light of Current Epidemic Threats: Unjustified Postponement
  72. Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries
  73. Treatment of acute pharyngitis
  74. Impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later
  75. Response to Letter to the Editor re ‘Urinary tract infection in children: Diagnosis, treatment, imaging – Comparison of current guidelines’
  76. Hyperbaric Oxygen Therapy (HBOT) in Pediatrics
  77. Leczenie przeciwwirusowe grypy
  78. Antibody Response to Trivalent Influenza Vaccine in the Northern and the Southern Hemisphere in Elite Athletes
  79. Knowledge Regarding Influenza and Influenza Vaccination in General Population: Results of a National Survey in Poland
  80. Urinary tract infection in children: Diagnosis, treatment, imaging – Comparison of current guidelines
  81. Spleen: Disorders
  82. Non-specific signs of neuroinfection after a tick bite in a 10-year-old boy – a case report
  83. Benign Acute Childhood Myositis During Influenza B Outbreak
  84. Evaluation of the Implementation of Hospital Antibiotic Policy in Oncosurgery Ward: A Six-Year Experience
  85. Healthcare Professionals’ Knowledge of Influenza and Influenza Vaccination: Results of a National Survey in Poland
  86. Pertussis outbreak in Polish shooters with adverse event analysis
  87. Public Perception of the Risks Associated with Infectious Diseases in Poland: Ebola and Influenza and Their Impact on the Attitude to Vaccination
  88. Rapid Influenza Diagnostic Tests Improve Suitability of Antiviral Treatment in Hospitalized Children
  89. Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki disease
  90. Influenza vaccination: key facts for general practitioners in Europe—a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands
  91. Clinical Presentation of Herpes Zoster in Immunocompetent and Immunocompromised Hospitalized Children Treated With Acyclovir
  92. Zika virus infection – a new epidemic threat
  93. Polish consensus guidelines on the use of acyclovir in the treatment and prevention of VZV and HSV infections
  94. Awareness of Influenza and Attitude Toward Influenza Vaccination Among Medical Students
  95. Gastroesophageal Reflux Disease in Children with Interstitial Lung Disease
  96. Pertussis: History of the Disease and Current Prevention Failure
  97. Rapid Influenza Diagnostic Tests - Indications, Clinical Implications and Usefulness
  98. Current recommendations regarding vaccinations in asplenia and hyposplenia
  99. Incidence and Clinical Course of Respiratory Viral Coinfections in Children Aged 0–59 Months
  100. Usage of Over-the-Counter and Herbal Products in Common Cold in Poland: Findings from Consumer Survey
  101. Pathophysiology of Clinical Symptoms in Acute Viral Respiratory Tract Infections